{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-3.0","upperLimit":"4.4","value":"1.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"}],"units":"Participants"}],"description":"Change from baseline in hemoglobin after treatment with high-dose Epoetin Alfa.","dispersionType":"Full Range","groups":[{"description":"Epoetin Alfa will be administered 80,000 units subcutaneously every week beginning on Day 1. On Day 28, the dose was adjusted based upon patients' Hemoglobin Levels\n\nepoetin alfa: Epoetin alfa will be administered 80,000 u sc every week commencing on study day 1.","id":"OG000","title":"Epoetin Alfa - 80,000 U sc"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Baseline to Day 28","title":"Change From Baseline in Hemoglobin at Day 28","type":"PRIMARY","unitOfMeasure":"g/dL"}